No Data
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
Tectonic Therapeutic Price Target Announced at $65.00/Share by Raymond James
Raymond James Initiates Tectonic Therapeutic(TECX.US) With Buy Rating, Announces Target Price $65
Tectonic Therapeutic Initiated With an Outperform at Raymond James
Tectonic Therapeutic Inc. Faces Challenges With Australian Subsidiary Amid Regulatory and Operational Risks
No Data
No Data
